Zlatko Dembic

Has grant

Professor I (immunology, cell biology, microbiology) tenured

University of Oslo

Norway

Research Interests

Explore related searches

Professors in Norway Professors in Immunology Immunology professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor I Zlatko Dembic is a tenured faculty member at the University of Oslo, Norway. His research focuses on immunology, cell biology, and microbiology, with recent publications examining the role of microRNA in osteoarthritis and genetic polymorphisms associated with injuries in athletes. He contributes to the understanding of immune system integration and defense mechanisms in various pathologies.

Recent Grants

Grant: Close

Molecular Genetics of the Immune System

Open Date: 2002-09-01

Close Date:

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (1)

peter Bretscher

Professor

University of Saskatchewan

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zlatko Dembic

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (11)

Indirect influence of microRNA‐146a on the association of IL‐6 and TNF‐α genetic polymorphisms with the increased risk of hip osteoarthritis

MMP3 single‐nucleotide polymorphisms are associated with noncontact ACL injuries in competing high‐level athletes

MMP3 single-nucleotide polymorphisms are associated with noncontact ACL injuries in competing high-level athletes

The Role of MicroRNA Molecules in Osteoarthritis Pathogenesis,Uloga mikroRNK molekula u patogenezi osteoartritisa

Defending and integrating an organism by the immune system

Defending and integrating an organism by the immune system

Obituary: Dr Zoltan A. Nagy (1941–2020)

Obituary: Dr Zoltan A. Nagy (1941-2020)

Jacob B. Natvig (1934-2021), one of the founders of Scandinavian Journal of Immunology OBITURY

Antitumor Drugs and Their Targets.

Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint

Collaborators (1)

peter Bretscher

Make your next move.